Garden State Life Sciences Venture
3
39M
2
0.33
2
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Philadelphia. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the Garden State Life Sciences Venture, startups are often financed by CHL Medical Partners, Radius Ventures, Prospect Venture Partners. The meaningful sponsors for the fund in investment in the same round are Quaker BioVentures, Radius Ventures, Prospect Venture Partners. In the next rounds fund is usually obtained by GlaxoSmithKline.
We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Among the most popular portfolio startups of the fund, we may highlight Amicus Therapeutics, EKR Therapeutics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2012. The high activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.33
- Investments by industry
- Therapeutics (3)
- Health Care (3)
- Pharmaceutical (3)
- Biotechnology (3)
- Pharmaceuticals (2) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 75M
- Group Appearance index
- 1.00
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EKR Therapeutics | 15 Aug 2007 | Therapeutic Devices, Biotechnology, Pharmaceuticals, Health Care, Pharmaceutical, Therapeutics | Late Stage Venture | 13M | United States, New Jersey |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.